PRKN mutations have been strongly implicated not only in the early-onset of PD—accounting for approximately 10–20% of cases with onset between ages 40 and 50, and up to 42% of cases with onset at or before age 20—but also in the broader pathogenesis and progression of the disease [56,57,58,59]. The gene discussed is PRKN; the disease is Parkinson disease.